Adlai Nortye Ltd. Sponsored ADR (ANL)
(Delayed Data from NSDQ)
$2.15 USD
-0.05 (-2.27%)
Updated Sep 9, 2024 03:59 PM ET
After-Market: $2.21 +0.06 (2.79%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (86 out of 249)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.37 | 9.99 |
Current Quarter Estimate | NA | -10.49 | 61.00 |
Year Ago Quarter Estimate | NA | -3.45 | 54.84 |
Next Quarter Estimate | NA | 2.89 | 63.00 |
Next Year Estimate | -0.92 | 25.11 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 77.55 | 17.50 | 15.67 |
Next Year | 43.56 | 9.40 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -7.39 |
Price/Book (MRQ) | 1.52 | 2.05 |
Price/Cash Flow (MRFY) | NA | 17.40 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -147.72% |
Return on Equity (TTM) | NA | -60.91% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.